National Heatwave Plan to be activated on 10 August After consulting the Royal Netherlands Meteorological Institute (KNMI), RIVM has decided to activate the National Heatwave Plan in all Dutch provinces as of 10 August 2022.
Side effect reports National Immunisation Programme 2021 Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
National Heatwave Plan no longer in effect, smog alert withdrawn As of Thursday, 21 July 2022, the National Heatwave Plan is no longer in effect. RIVM also withdraws the smog alert.
Smog alert in the Netherlands Tuesday 19 July Just as in recent days, today 19 July there is a risk of smog across the Netherlands due to high ozone concentrations.
National Heatwave Plan active as of 18 July and smog warning throughout the Netherlands It is warm and the heat will continue over the coming days. For many people, this means enjoying the beach or garden. For others, heat can be less enjoyable.
Reminders for booster jab and repeat vaccination against COVID-19 Adults who have not yet had a booster jab or repeat vaccination against COVID-19 will receive a reminder letter from RIVM, starting Friday 8 July 2022.
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
COVID-19 vaccination figures more up-to-date due to optimised monitoring RIVM has been publishing national and regional figures on COVID-19 vaccination in the Netherlands every week since 19 January 2021.
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26 From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Tailor-made information will help immigrants make decisions on taking part in screening programmes Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.